Subbu Sarma, MD
Addiction Medicine · Lees Summit, MONPI 1689661829
Payments from drug & device makers
Across 666 payments — averaging $225.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$122K
- E.r. Squibb & Sons, L.L.C.$13K
- Idorsia Pharmaceuticals US Inc$7K
- Otsuka America Pharmaceutical, Inc.$1K
- Alkermes, Inc.$1K
- AbbVie$769
- plus $5K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 200 | $121,561 |
| E.r. Squibb & Sons, L.L.C. | 54 | $13,417 |
| Idorsia Pharmaceuticals US Inc | 7 | $7,188 |
| Otsuka America Pharmaceutical, Inc. | 64 | $1,193 |
| Alkermes, Inc. | 51 | $1,056 |
| AbbVie(2 entities) | 44 | $769 |
| Axsome Therapeutics, Inc. | 24 | $737 |
| Neurocrine Biosciences, Inc. | 31 | $733 |
| Lundbeck LLC | 37 | $715 |
| Johnson & Johnson | 30 | $642 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 33 | $586 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $424 |
| Vanda Pharmaceuticals Inc. | 16 | $421 |
| Corium, LLC | 10 | $142 |
| Acadia Pharmaceuticals Inc | 4 | $124 |
| Noven Therapeutics, LLC | 7 | $122 |
| Merck | 6 | $112 |
| Indivior Inc. | 5 | $96 |
| Almatica Pharma LLC | 3 | $60 |
| Shire North American Group Inc | 3 | $48 |
| Tris Pharma Inc | 2 | $47 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 2 | $34 |
| Neos Therapeutics, LP | 2 | $30 |
| Biogen | 1 | $28 |
| Janssen Scientific Affairs, LLC | 2 | $25 |
| Sage Therapeutics, LLC | 1 | $15 |
| Eisai Inc. | 1 | $13 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Neuronetics, Inc. | 1 | $11 |
How this compares
Too few addiction medicine providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other addiction medicine in Lees Summit
- David SternbergLees Summit$93
- Sarfaraz JasdanwalaRolla$26K
- Beenish ZaidiDittmer$12K
- Mehdi TajouriSpringfield$1K
- Shawn StranckmeyerSpringfield$974
- Jose Perez MartellKansas City$690
- Robert CorderSaint Joseph$636
- Rocksheng ZhongClinton$251
- Amanda HilmerSaint Louis$220
- Gary HammenKirkwood$188
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.